OncoK9 – VCS 2021 Presentation - PetDx®

OncoK9 – VCS 2021 Presentation

What is OncoK9?

PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9™, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms empowering veterinarians to provide superior care to canine patients.


To learn more about OncoK9, visit petdx.com. To access scientific resources like our white paper and peer-reviewed publications, please visit petdx.com/resources/.

Be among the first to offer this revolutionary technology

We’d love to talk with you about offering OncoK9 in your veterinary practice. Please email sales@petdx.com at or call (858) 224-9046.


Join the Revolution in Early Cancer Detection for Dogs

If you are eager to incorporate breakthrough innovation into your veterinary practice, we would love to partner with you. Be among the first to offer our pioneering multi-cancer early detection test to your canine patients. Provide your name and email address and we will reach out as we expand our rollout.

Email Address *

First Name *

Last Name *

Practice Name *

Position/Role *

Zip Code *

Please input numbers only

Phone Number

Please input numbers only

Lead Source


Web Form



* required field